Dyne Therapeutics, Inc. (DYN)
↓ Download CSVKey ratios (FY2025)
-45.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$468.18M | -$343.89M | -$242.16M | -$170.96M | -$150.03M | -$58.65M | -$13.83M | — |
| Net Income | -$446.21M | -$317.42M | -$235.94M | -$168.10M | -$149.29M | -$59.44M | -$14.86M | — |
| EPS (Diluted) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | — | — | — |
| Total Assets | $1.19B | $691.23M | $165.08M | $306.32M | $425.66M | $353.33M | $16.44M | — |
| Total Liabilities | $214.83M | $61.40M | $73.79M | $53.96M | $57.47M | $10.97M | $2.40M | — |
| Shareholders' Equity | $972.13M | $629.84M | $91.29M | $252.36M | $368.20M | $342.37M | $14.04M | -$4.88M |
| Cash & Equivalents | $893.37M | $435.45M | $121.63M | $172.15M | $200.82M | $300.85M | $14.63M | — |
| Operating Cash Flow | -$403.21M | -$292.37M | -$188.16M | -$153.65M | -$119.56M | -$46.51M | -$11.83M | — |
| Capital Expenditures | $1.92M | $2.38M | $729.0K | $3.07M | $3.62M | $1.16M | $1.65M | — |
| Shares Outstanding | 164.95M | 102.32M | 61.47M | 55.64M | 51.57M | 45.08M | 2.59M | — |